نتائج البحث - Mojgan Rahimi

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Optimal dose of pre-incision/post-incision gabapentin for pain relief following lumbar laminectomy: a randomized study

    Optimal dose of pre-incision/post-incision gabapentin for pain relief following lumbar laminectomy: a randomized study حسب Zahid Hussain Khan, Mojgan Rahimi, Jalil Makarem, Razmeh Hussain Khan

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit

    Mortality Predictive Value of APACHE II and SOFA Scores in COVID-19 Patients in the Intensive Care Unit حسب Mohammad Taghi Beigmohammadi, Laya Amoozadeh, Forough Rezaei Motlagh, Mojgan Rahimi, Maziar Maghsoudloo, Behzad Jafarnejad, Babak Eslami, Mohammad Reza Salehi, Kazem Zendehdel

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Resistant Perianal Fistula in IBD patients; Clinical Trial Phase I

    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Resistant Perianal Fistula in IBD patients; Clinical Trial Phase I حسب Hojjatollah Nazari, Asieh Heirani, Masoud Soleimani, Reza Akbari Asbagh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Foroogh Alborzi Avanaki, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Refractory Perianal Fistula in IBD patients; Clinical Trial Phase I

    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Refractory Perianal Fistula in IBD patients; Clinical Trial Phase I حسب Hojjatollah Nazari, Asieh Heirani, Masoud Soleimani, Reza Akbari Asbagh, Alireza Hadizadeh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Foroogh Alborzi Avanaki, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I

    Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I حسب Hojjatollah Nazari, Foroogh Alborzi Avanaki, Asieh Heirani‐Tabasi, Alireza Hadizadeh, Reza Akbari Asbagh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Masoud Soleimani, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: